These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 1756132

  • 1. Stunning: a radical re-view.
    Hearse DJ.
    Cardiovasc Drugs Ther; 1991 Oct; 5(5):853-76. PubMed ID: 1756132
    [Abstract] [Full Text] [Related]

  • 2. [Hibernation, stunning, ischemic preconditioning--new paradigms in coronary disease?].
    Heusch G.
    Z Kardiol; 1992 Nov; 81(11):596-609. PubMed ID: 1471397
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of myocardial "stunning".
    Bolli R.
    Circulation; 1990 Sep; 82(3):723-38. PubMed ID: 2203553
    [Abstract] [Full Text] [Related]

  • 4. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.
    Kloner RA, Jennings RB.
    Circulation; 2001 Dec 11; 104(24):2981-9. PubMed ID: 11739316
    [Abstract] [Full Text] [Related]

  • 5. Stunning: damaging or protective to the myocardium?
    Ferrari R, Visioli O.
    Cardiovasc Drugs Ther; 1991 Oct 11; 5(5):939-45. PubMed ID: 1756141
    [Abstract] [Full Text] [Related]

  • 6. Molecular and cellular mechanisms of myocardial stunning.
    Bolli R, Marbán E.
    Physiol Rev; 1999 Apr 11; 79(2):609-34. PubMed ID: 10221990
    [Abstract] [Full Text] [Related]

  • 7. Myocardial stunning: do we know the mechanism?
    Shattock MJ.
    Basic Res Cardiol; 1997 Apr 11; 92 Suppl 2():18-22. PubMed ID: 9457363
    [Abstract] [Full Text] [Related]

  • 8. Metabolic disturbances during myocardial ischemia and reperfusion.
    Ferrari R.
    Am J Cardiol; 1995 Aug 24; 76(6):17B-24B. PubMed ID: 7645523
    [Abstract] [Full Text] [Related]

  • 9. The pathophysiology of myocardial stunning: reversibility, accumulation and continuity of the ischemic myocardial damage after reperfusion.
    Miura M, Matsu-oka H, Saito T, Kanazawa T.
    Jpn Circ J; 1991 Sep 24; 55(9):868-77. PubMed ID: 1658410
    [Abstract] [Full Text] [Related]

  • 10. Use of spin traps in intact animals undergoing myocardial ischemia/reperfusion: a new approach to assessing the role of oxygen radicals in myocardial "stunning".
    Bolli R, McCay PB.
    Free Radic Res Commun; 1990 Sep 24; 9(3-6):169-80. PubMed ID: 2167254
    [Abstract] [Full Text] [Related]

  • 11. Diastolic Ca2+ overload caused by Na+/Ca2+ exchanger during the first minutes of reperfusion results in continued myocardial stunning.
    Wei GZ, Zhou JJ, Wang B, Wu F, Bi H, Wang YM, Yi DH, Yu SQ, Pei JM.
    Eur J Pharmacol; 2007 Oct 15; 572(1):1-11. PubMed ID: 17822695
    [Abstract] [Full Text] [Related]

  • 12. Mitochondrial Bioenergetics During Ischemia and Reperfusion.
    Consolini AE, Ragone MI, Bonazzola P, Colareda GA.
    Adv Exp Med Biol; 2017 Oct 15; 982():141-167. PubMed ID: 28551786
    [Abstract] [Full Text] [Related]

  • 13. Characterization of "hibernating" and "stunned" myocardium with focus on the use of calcium antagonists in "stunned" myocardium.
    Ehring T, Schulz R, Heusch G.
    J Cardiovasc Pharmacol; 1992 Oct 15; 20 Suppl 5():S25-33. PubMed ID: 1282610
    [Abstract] [Full Text] [Related]

  • 14. Clinical and experimental aspects of myocardial stunning.
    Scott BD, Kerber RE.
    Prog Cardiovasc Dis; 1992 Oct 15; 35(1):61-76. PubMed ID: 1529099
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of postischemic contractile dysfunction.
    Gross GJ, Kersten JR, Warltier DC.
    Ann Thorac Surg; 1999 Nov 15; 68(5):1898-904. PubMed ID: 10585101
    [Abstract] [Full Text] [Related]

  • 16. Clinical relevance of myocardial "stunning".
    Bolli R, Hartley CJ, Rabinovitz RS.
    Cardiovasc Drugs Ther; 1991 Oct 15; 5(5):877-90. PubMed ID: 1756133
    [Abstract] [Full Text] [Related]

  • 17. Cardiomyocytes from hearts with left ventricular dysfunction after ischemia-reperfusion do not manifest contractile abnormalities.
    Chandrashekhar Y, Prahash AJ, Sen S, Gupta S, Anand IS.
    J Am Coll Cardiol; 1999 Aug 15; 34(2):594-602. PubMed ID: 10440178
    [Abstract] [Full Text] [Related]

  • 18. Postischemic stunning: the two-phase model for the role of calcium as pathogen.
    Opie LH, du Toit EF.
    J Cardiovasc Pharmacol; 1992 Aug 15; 20 Suppl 5():S1-4. PubMed ID: 1282606
    [Abstract] [Full Text] [Related]

  • 19. Pathogenetic role for calcium in stunning?
    Marban E.
    Cardiovasc Drugs Ther; 1991 Oct 15; 5(5):891-3. PubMed ID: 1756134
    [Abstract] [Full Text] [Related]

  • 20. Effect of brief regional ischemia followed by reperfusion with or without superoxide dismutase and catalase administration on myocardial sarcoplasmic reticulum and contractile function.
    Rehr RB, Fuhs BE, Hirsch JI, Feher JJ.
    Am Heart J; 1991 Nov 15; 122(5):1257-69. PubMed ID: 1950987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.